GLP-1 drugs show potential to slow cancer spread, study suggests

A new study suggests GLP-1 receptor agonists, drugs commonly used to treat diabetes and obesity, may reduce the risk of cancer spread in certain cancers, a finding that could point to drug repurposing but requires further research to confirm which cancers might benefit and to establish clinical relevance.